Schedule 13D ownership disclosure

Idera Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 45168K405

Event date: 2019-06-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,898,847
Percent of class
17.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-030116
Form type
SC 13D/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Jun 06, 2019
Reporting period
Jun 04, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub